Last update :
17/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Glucose-lowering   Insulin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Actrapid Texte introuvable (616, ), Austria, Belgium, Croatia, Denmark, Finland, France, Great Britain, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Republic of South Africa, Russian, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey
Bioinsugen Chile
Biosulin Russian
Gensulin Poland
Humaject Croatia, Poland, Slovenia
Humaplus Spain
Humasulin Austria, Switzerland
Humasulina Spain
Humulin R Texte introuvable (616, ), Canada, Croatia, Denmark, Great Britain, Greece, Poland, Republic of South Africa, Slovenia, Turkey, United States of America
Humuline Belgium, Netherlands
Insuman Texte introuvable (616, ), Austria, Denmark, Finland, France, Great Britain, Ireland, Netherlands, Norway, Russian, Sweden, Switzerland
Isuhuman Portugal
Novolin Canada
Umuline France
Velosulin Texte introuvable (616, ), Austria, Belgium, France
Velosuline United States of America
Stability in solutions   Injection   Stability in solutions : Insulin     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride Sodium chloride 0,9% 0,1 UI/ml 2-8°C Protect from light
8 Day
2091
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0,1 UI/ml 25°C Protect from light
24 Hour
2091
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0,1 UI/ml 37°C Protect from light
24 Hour
2091
Level of evidence D
Polyvinyl chloride Dianéal® PD4 1.36% glucose (Baxter) 0,004 UI/ml 25°C Not specified
24 Hour
2164

Polyvinyl chloride Dianéal® PD4 1.36% glucose (Baxter) 0,01 UI/ml 25°C Not specified
24 Hour
2164

Polyvinyl chloride Dianéal® PD4 1.36% glucose (Baxter) 0,02 UI/ml 25°C Not specified
24 Hour
2164

Polyvinyl chloride Dianéal® PD4 1.36% glucose (Baxter) 0,04 UI/ml 25°C Not specified
24 Hour
2164

Polyvinyl chloride Physionéal® 1.36 (Baxter) 0,01 UI/ml 25°C Not specified
6 Hour
2164

Polyvinyl chloride Physionéal® 1.36 (Baxter) 0,02 UI/ml 25°C Not specified
6 Hour
2164

Polyvinyl chloride Physionéal® 1.36 (Baxter) 0,04 UI/ml 25°C Not specified
6 Hour
2164

Polyethylene None 100 UI/ml 37°C Protect from light
48 Hour
803
Level of evidence B
Polyethylene Physionéal® 1.36 (Baxter) 0,01 UI/ml 25°C Not specified
6 Hour
2164

Polyethylene Physionéal® 1.36 (Baxter) 0,02 UI/ml 25°C Not specified
6 Hour
2164

Polyethylene Physionéal® 1.36 (Baxter) 0,04 UI/ml 25°C Not specified
6 Hour
2164

Polypropylene and polyethylene None 100 UI/ml 3-5°C Protect from light
28 Day
468
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 1 UI/ml 2-6°C Protect from light
180 Day
3224

Polypropylen Syringe Sodium chloride 0,9% 1 UI/ml 2-8°C Protect from light
21 Day
4635
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 UI/ml 20-25°C Light
48 Hour
4635
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 UI/ml 23-27°C Not specified
30 Day
3224

Polypropylen Syringe None 100 UI/ml 3-5°C Protect from light
28 Day
468
Level of evidence B
Polypropylen Syringe None 500 UI/ml 4°C Not specified
28 Day
4309
Level of evidence B
  Mentions Légales